PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PHGE vs. ARCC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PHGE and ARCC is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

PHGE vs. ARCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BiomX Inc. (PHGE) and Ares Capital Corporation (ARCC). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2025February
-33.10%
17.05%
PHGE
ARCC

Key characteristics

Sharpe Ratio

PHGE:

-0.27

ARCC:

2.24

Sortino Ratio

PHGE:

0.73

ARCC:

2.99

Omega Ratio

PHGE:

1.09

ARCC:

1.41

Calmar Ratio

PHGE:

-0.61

ARCC:

3.92

Martin Ratio

PHGE:

-0.84

ARCC:

16.30

Ulcer Index

PHGE:

71.67%

ARCC:

1.67%

Daily Std Dev

PHGE:

225.93%

ARCC:

12.19%

Max Drawdown

PHGE:

-99.54%

ARCC:

-79.36%

Current Drawdown

PHGE:

-99.15%

ARCC:

-1.72%

Fundamentals

Market Cap

PHGE:

$17.27M

ARCC:

$15.76B

EPS

PHGE:

-$3.26

ARCC:

$2.44

Total Revenue (TTM)

PHGE:

-$2.19M

ARCC:

$2.77B

Gross Profit (TTM)

PHGE:

-$2.75M

ARCC:

$2.61B

EBITDA (TTM)

PHGE:

$311.00K

ARCC:

$703.00M

Returns By Period

In the year-to-date period, PHGE achieves a 25.17% return, which is significantly higher than ARCC's 6.90% return.


PHGE

YTD

25.17%

1M

19.56%

6M

-32.80%

1Y

-59.38%

5Y*

-61.13%

10Y*

N/A

ARCC

YTD

6.90%

1M

0.13%

6M

17.11%

1Y

28.04%

5Y*

14.83%

10Y*

13.63%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PHGE vs. ARCC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PHGE
The Risk-Adjusted Performance Rank of PHGE is 3535
Overall Rank
The Sharpe Ratio Rank of PHGE is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of PHGE is 5252
Sortino Ratio Rank
The Omega Ratio Rank of PHGE is 5050
Omega Ratio Rank
The Calmar Ratio Rank of PHGE is 1212
Calmar Ratio Rank
The Martin Ratio Rank of PHGE is 2828
Martin Ratio Rank

ARCC
The Risk-Adjusted Performance Rank of ARCC is 9494
Overall Rank
The Sharpe Ratio Rank of ARCC is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of ARCC is 9191
Sortino Ratio Rank
The Omega Ratio Rank of ARCC is 9191
Omega Ratio Rank
The Calmar Ratio Rank of ARCC is 9696
Calmar Ratio Rank
The Martin Ratio Rank of ARCC is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PHGE vs. ARCC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BiomX Inc. (PHGE) and Ares Capital Corporation (ARCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PHGE, currently valued at -0.27, compared to the broader market-2.000.002.00-0.272.24
The chart of Sortino ratio for PHGE, currently valued at 0.73, compared to the broader market-4.00-2.000.002.004.006.000.732.99
The chart of Omega ratio for PHGE, currently valued at 1.09, compared to the broader market0.501.001.502.001.091.41
The chart of Calmar ratio for PHGE, currently valued at -0.61, compared to the broader market0.002.004.006.00-0.613.92
The chart of Martin ratio for PHGE, currently valued at -0.84, compared to the broader market-10.000.0010.0020.0030.00-0.8416.30
PHGE
ARCC

The current PHGE Sharpe Ratio is -0.27, which is lower than the ARCC Sharpe Ratio of 2.24. The chart below compares the historical Sharpe Ratios of PHGE and ARCC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
-0.27
2.24
PHGE
ARCC

Dividends

PHGE vs. ARCC - Dividend Comparison

PHGE has not paid dividends to shareholders, while ARCC's dividend yield for the trailing twelve months is around 8.21%.


TTM20242023202220212020201920182017201620152014
PHGE
BiomX Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ARCC
Ares Capital Corporation
8.21%8.77%9.59%10.12%7.65%9.47%9.01%9.88%9.67%9.22%11.02%10.06%

Drawdowns

PHGE vs. ARCC - Drawdown Comparison

The maximum PHGE drawdown since its inception was -99.54%, which is greater than ARCC's maximum drawdown of -79.36%. Use the drawdown chart below to compare losses from any high point for PHGE and ARCC. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.15%
-1.72%
PHGE
ARCC

Volatility

PHGE vs. ARCC - Volatility Comparison

BiomX Inc. (PHGE) has a higher volatility of 26.95% compared to Ares Capital Corporation (ARCC) at 4.74%. This indicates that PHGE's price experiences larger fluctuations and is considered to be riskier than ARCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
26.95%
4.74%
PHGE
ARCC

Financials

PHGE vs. ARCC - Financials Comparison

This section allows you to compare key financial metrics between BiomX Inc. and Ares Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab